Caffeine Consumption in Glaucoma Patients and Healthy Subjects (NCT03675412) | Clinical Trial Compass
RecruitingNot Applicable
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
United States80 participantsStarted 2018-12-30
Plain-language summary
Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.
Who can participate
Age range18 Years – 90 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age 18 to 90 years
* diagnosis of primary open angle glaucoma (Mild, Moderate and Advanced)
* healthy subjects with no eye disease
Exclusion Criteria:
* Diseases, ophthalmic or systemic, that are likely to affect OCTA results
* greater than moderate cataract
* nystagmus
* inability to look at target
* macular degeneration other than mild drusen or pigmentary changes
* diabetic retinopathy
* neovascular glaucoma or non-glaucoma optic neuropathies
* current macular edema, prior laser to retina, inflammatory retinopathy or choroidopathy
* keratoconus, corneal ectasia, central corneal scarring
* rheumatologic diseases or Raynaud's phenomena
* pregnant and lactating women
* mental illness or alcohol addiction
* pre-existing bladder symptoms, cardiac disease or sleep disorder
* refractive spherical diopter greater than 5 or cylinder greater than 3
* possible tolerance to caffeine (drinking more than 1 cup coffee per day).
What they're measuring
1
Blood flow change in back of eye before and after caffeine